Dr. Richard Cherny, M.D

NPI: 1659351484
Total Payments
$530.53
2024 Payments
$18.09
Companies
13
Transactions
18
Medicare Patients
26,707
Medicare Billing
$22.7M

Payment Breakdown by Category

Food & Beverage$312.26 (58.9%)
Education$184.57 (34.8%)
Gifts$33.70 (6.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $312.26 10 58.9%
Education $184.57 7 34.8%
Gift $33.70 1 6.4%

Top Paying Companies

Company Total Records Latest Year
Sirtex Medical Inc $122.98 1 $0 (2019)
Astellas Pharma US Inc $98.95 1 $0 (2020)
Elekta, Inc. $91.36 1 $0 (2019)
PFIZER INC. $50.24 4 $0 (2023)
Merck Sharp & Dohme LLC $42.60 3 $0 (2024)
Welch Allyn $33.70 1 $0 (2020)
Celgene Corporation $18.58 1 $0 (2017)
E.R. Squibb & Sons, L.L.C. $17.33 1 $0 (2020)
Karyopharm Therapeutics Inc. $12.45 1 $0 (2020)
Acrotech Biopharma LLC $11.97 1 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $18.09 1 Merck Sharp & Dohme LLC ($18.09)
2023 $13.86 1 PFIZER INC. ($13.86)
2021 $23.89 2 Acrotech Biopharma LLC ($11.97)
2020 $174.67 5 Astellas Pharma US Inc ($98.95)
2019 $259.21 6 Sirtex Medical Inc ($122.98)
2018 $11.41 1 Novocure Inc. ($11.41)
2017 $29.40 2 Celgene Corporation ($18.58)

All Payment Transactions

18 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
06/05/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological) Education In-kind items and services $18.09 General
Category: ONCOLOGY
04/10/2023 PFIZER INC. XTANDI (Drug) Education In-kind items and services $13.86 General
Category: ONCOLOGY
06/01/2021 Gilead Sciences, Inc. Education In-kind items and services $11.92 General
04/13/2021 Acrotech Biopharma LLC BELEODAQ (Drug) Education In-kind items and services $11.97 General
Category: ONCOLOGY
11/17/2020 Karyopharm Therapeutics Inc. XPOVIO (Drug) Education In-kind items and services $12.45 General
Category: Oncology
08/17/2020 Astellas Pharma US Inc Education In-kind items and services $98.95 General
08/17/2020 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Education Cash or cash equivalent $17.33 General
Category: Oncology
05/06/2020 Welch Allyn None (Device) Gift In-kind items and services $33.70 General
Category: Not Applicable
03/12/2020 PFIZER INC. RUXIENCE (Biological) Food and Beverage In-kind items and services $12.24 General
Category: ONCOLOGY
10/24/2019 Merck Sharp & Dohme Corporation KEYTRUDA (Biological) Food and Beverage In-kind items and services $13.69 General
Category: ONCOLOGY
10/02/2019 Sirtex Medical Inc SIR-Spheres Microspheres (Device) Food and Beverage Cash or cash equivalent $122.98 General
Category: Interventional Oncology
07/12/2019 PFIZER INC. MYLOTARG (Biological), DAURISMO Food and Beverage In-kind items and services $12.31 General
Category: ONCOLOGY
06/02/2019 Elekta, Inc. Versa HD (Device), Mosaiq, Esteya Food and Beverage Cash or cash equivalent $91.36 General
Category: ELEKTA LINEAR ACCELERATOR
02/15/2019 Clovis Oncology, Inc. Rubraca (Drug) Food and Beverage In-kind items and services $7.04 General
Category: Oncology
02/13/2019 PFIZER INC. DAURISMO (Drug) Food and Beverage In-kind items and services $11.83 General
Category: ONCOLOGY
05/08/2018 Novocure Inc. Oncology (Device) Food and Beverage Cash or cash equivalent $11.41 General
Category: Optune
06/01/2017 Celgene Corporation Revlimid (Drug) Food and Beverage In-kind items and services $18.58 General
Category: Hematology / Oncology
03/23/2017 Merck Sharp & Dohme Corporation EMEND (Drug), KEYTRUDA Food and Beverage In-kind items and services $10.82 General
Category: ONCOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 114 6,604 449,020 $17.5M $6.3M
2022 110 6,650 457,366 $17.0M $6.1M
2021 118 7,172 418,126 $16.9M $6.1M
2020 111 6,281 338,215 $12.1M $4.3M
Total Patients
26,707
Total Services
1,662,727
Medicare Billing
$22.7M
Procedure Codes
453

All Medicare Procedures & Services

453 procedure records from CMS Medicare Utilization — Page 3 of 19

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
J9190 Injection, fluorouracil, 500 mg Office 2023 47 1,736 $10,416 $3,258 31.3%
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion Office 2023 66 195 $10,725 $2,970 27.7%
96409 Administration of chemotherapy into vein using push technique Office 2023 17 42 $11,340 $2,951 26.0%
82784 Gammaglobulin (immune system protein) measurement Office 2023 62 300 $8,100 $2,734 33.8%
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour Office 2023 64 169 $9,464 $2,658 28.1%
96360 Infusion into a vein for hydration, 31-60 minutes Office 2023 55 105 $14,175 $2,646 18.7%
J3489 Injection, zoledronic acid, 1 mg Office 2023 51 366 $10,980 $2,350 21.4%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 31 31 $6,851 $2,252 32.9%
J1756 Injection, iron sucrose, 1 mg Office 2023 24 13,800 $27,600 $2,057 7.5%
82728 Ferritin (blood protein) level Office 2023 96 154 $6,006 $2,047 34.1%
96374 Injection of drug or substance into vein Office 2023 37 68 $9,105 $1,956 21.5%
38222 Biopsy and aspiration of bone marrow sample for diagnosis Office 2023 14 14 $4,298 $1,785 41.5%
J9171 Injection, docetaxel, 1 mg Office 2023 18 3,789 $18,945 $1,749 9.2%
96523 Irrigation of implanted venous access drug delivery device Office 2023 26 88 $6,688 $1,726 25.8%
J9206 Injection, irinotecan, 20 mg Office 2023 21 945 $5,670 $1,716 30.3%
J2997 Injection, alteplase recombinant, 1 mg Office 2023 11 28 $4,452 $1,663 37.4%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 15 15 $4,245 $1,523 35.9%
J9263 Injection, oxaliplatin, 0.5 mg Office 2023 31 26,629 $26,629 $1,490 5.6%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 19 24 $3,600 $1,483 41.2%
90662 Influenza vaccine split virus, preservative free Office 2023 20 20 $2,280 $1,435 62.9%
J9196 Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mg Office 2023 18 441 $5,292 $1,316 24.9%
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Office 2023 84 11,735 $11,735 $1,294 11.0%
J9201 Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg Office 2023 19 409 $8,998 $1,075 12.0%
84443 Blood test, thyroid stimulating hormone (tsh) Office 2023 18 64 $3,136 $1,053 33.6%
71250 Ct scan of chest without contrast Office 2023 14 18 $6,552 $972.24 14.8%

About Dr. Richard Cherny, M.D

Dr. Richard Cherny, M.D is a Hematology & Oncology healthcare provider based in East Syracuse, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659351484.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Cherny, M.D has received a total of $530.53 in payments from pharmaceutical and medical device companies, with $18.09 received in 2024. These payments were reported across 18 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($312.26).

As a Medicare-enrolled provider, Cherny has provided services to 26,707 Medicare beneficiaries, totaling 1,662,727 services with total Medicare billing of $22.7M. Data is available for 4 years (2020–2023), covering 453 distinct procedure/service records.

Practice Information

  • Specialty Hematology & Oncology
  • Location East Syracuse, NY
  • Active Since 01/18/2006
  • Last Updated 08/03/2018
  • Taxonomy Code 207RH0003X
  • Entity Type Individual
  • NPI Number 1659351484

Products in Payments

  • SIR-Spheres Microspheres (Device) $122.98
  • Versa HD (Device) $91.36
  • None (Device) $33.70
  • KEYTRUDA (Biological) $31.78
  • Revlimid (Drug) $18.58
  • OPDIVO (Biological) $17.33
  • XTANDI (Drug) $13.86
  • XPOVIO (Drug) $12.45
  • MYLOTARG (Biological) $12.31
  • RUXIENCE (Biological) $12.24
  • BELEODAQ (Drug) $11.97
  • DAURISMO (Drug) $11.83
  • Oncology (Device) $11.41
  • EMEND (Drug) $10.82
  • Rubraca (Drug) $7.04

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Hematology & Oncology Doctors in East Syracuse